FOLFIRINOX vs gemcitabine nab-paclitaxel: A real-world efficacy and safety analysis - a single-centre experience

被引:0
作者
Khan, A. M. [1 ]
Noor, S. [2 ]
Ahmed, R. [3 ]
Takreem, S. [2 ]
Shahnoor, S. S. [2 ]
Muddu, V. K. [2 ,4 ]
Bonda, A. [5 ]
Siripurapu, I. [5 ]
Krishnaiah, S. [6 ]
Rao, G. [7 ]
Reddy, N. [8 ]
机构
[1] Asian Inst Gastroenterol, Dept Med Oncol, Hyderabad, India
[2] Anwarul Uloom Coll Pharm, Pharm Practice, Hyderabad, India
[3] Anwarul Uloom Coll Pharm, Pharm, Hyderabad, India
[4] AIG Hosp Hyderabad, Med Oncol, Hyderabad, India
[5] AIG Hosp, Dept Med Oncol, Hyderabad, India
[6] Asian Inst Gastroenterol, Biostat, Hyderabad, India
[7] Asian Inst Gastroenterol, Surg Gastroenterol, Hyderabad, India
[8] Asian Inst Gastroenterol, Med Gastroenterol, Hyderabad, India
关键词
D O I
10.1016/j.annonc.2024.05.517
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
376P
引用
收藏
页码:S152 / S152
页数:1
相关论文
共 50 条
[31]   FOLFIRINOX and gemcitabine/nab-paclitaxel efficacy in the treatment of locally advanced unresectable pancreatic adenocarcinoma. [J].
Bednar, Filip ;
Ocuin, Lee Mayer ;
Steve, Jennifer ;
Zenati, Mazen S. ;
Winters, Sharon ;
Hogg, Melissa Ellen ;
Bahary, Nathan ;
Zeh, Herbert J. ;
Zureikat, Amer H. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
[32]   Upadacitinib real-world efficacy and safety in treatment of inflammatory bowel disease: an Australian single-centre experience [J].
Chen, Gordon ;
Rao, Vikram ;
Lo, Sheng Wei ;
Koh, Elaine ;
Kaul, Abha ;
La Nauze, Richard .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 :278-279
[33]   A real-world single-centre analysis of the safety and efficacy of cladribine tablets for relapsing multiple sclerosis [J].
Aerts, S. ;
Khan, H. ;
Severijns, D. ;
Popescu, V. ;
Peeters, L. M. ;
Van Wijmeersch, B. .
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) :892-892
[34]   Use of nab-paclitaxel and gemcitabine in pancreatic cancer without granulocyte colony-stimulating factor: A multicenter real-world experience [J].
Chen, Angela ;
Ha, Vincent H. ;
Ghosh, Sunita ;
Chambers, Carole R. ;
Sawyer, Michael B. .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (07) :1594-1602
[35]   Comparisons of Outcomes of Real-World Patients With Advanced Pancreatic Cancer Treated With FOLFIRINOX Versus Gemcitabine and Nab-Paclitaxel A Population-Based Cohort Study [J].
Papneja, Neha ;
Zaidi, Adnan ;
Chalchal, Haji ;
Moser, Michael ;
Tan, Kiat ;
Olson, Colleen ;
Haider, Kamal ;
Shaw, John ;
Ahmed, Shahid .
PANCREAS, 2019, 48 (07) :920-926
[36]   FOLFIRINOX versus gemcitabine nab-paclitaxel for advanced pancreatic cancer: KU Cancer Center experience. [J].
Kasi, Anup ;
Middinti, Akshay ;
Cao, An ;
Vekaria, Pratikkumar ;
Patel, Devangi ;
Subramaniam, Dipti ;
Chen, Guoqing J. ;
Saeed, Anwaar Mohammed ;
Paluri, Ravi Kumar .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[37]   Real-world efficacy and safety of naltrexone-bupropion therapy in Chinese patients with obesity: A single-centre experience [J].
Lui, David Tak Wai ;
Tsoi, Kimberly Hang ;
Fong, Carol Ho Yi ;
Jiang, Nancy Su ;
Chow, Wing Sun ;
Yuen, Michele Mae Ann .
ENDOCRINE, 2025, 87 (02) :522-529
[38]   Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience [J].
Abawi, M. ;
Nijhoff, F. ;
Stella, P. R. ;
Voskuil, M. ;
Benedetto, D. ;
Doevendans, P. A. ;
Agostoni, P. .
NETHERLANDS HEART JOURNAL, 2016, 24 (09) :544-551
[39]   Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience [J].
M. Abawi ;
F. Nijhoff ;
P.R. Stella ;
M. Voskuil ;
D. Benedetto ;
P.A. Doevendans ;
P. Agostoni .
Netherlands Heart Journal, 2016, 24 :544-551
[40]   ANALYSIS OF US REAL WORLD EVIDENCE DATA TO ASSESS AND COMPARE THE EFFECTIVENESS OF TWO CHEMOTHERAPY REGIMENS: FOLFIRINOX VS GEMCITABINE/NAB-PACLITAXEL FOR FIRST LINE METASTATIC PANCREATIC CANCER [J].
Bochenska, K. ;
Galusza, M. ;
Hodge, J. P. ;
Raupp, M. D. ;
Zeng, S. .
VALUE IN HEALTH, 2023, 26 (06) :S364-S364